Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Society for Laboratory Automation and Screening Fully Established

By LabMedica International staff writers
Posted on 04 Aug 2010
On July 1, 2010, after almost two years strategizing, the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA) united as one inclusive organization--the Society for Laboratory Automation and Screening (SLAS; IL, USA).

SBS and ALA will constitute individual sections of SLAS. More...
Each section will continue to pursue its current mission. The current SBS mission is to advance the science and technology of drug discovery and the use and development of biomolecular screening technology.

The current ALA mission is to further science and education related to laboratory automation, and in particular to encourage and advance the study and to improve the practice of laboratory automation.

SBS's and ALA's former identities and specialized educational programs will be preserved. Both will benefit from the expanded scope, international influence, and enhanced program and service offerings that the unified organization, SLAS, will provide.

The Journal for Biomolecular Screening (JBS) and Journal of the Association for Laboratory Automation (JALA) will continue their publishing schedules and immediate educational programs will take place as scheduled.

The CEO of SLAS, Greg Dummer, outlined the new society's aims. "Our objective right now is to be ready for business as a united new entity sometime later this year. With the traditional SBS and ALA conferences and exhibitions set for the first quarter of 2011, we have to maintain a high level of focus and determination; and we must look to appropriately blend some aspects of SLAS into each of these events."

During the transition period, which will take place throughout 2011, the new SLAS board of directors, with the leadership of the SBS and ALA sections will develop the long-range strategy.

The SALS is a not-for-profit corporation organized and operated exclusively for charitable, educational, and scientific purposes. Its aim is to be the preeminent global organization providing forums for education and information exchange pertaining to laboratory automation and screening.

Related Links:

Society for Biomolecular Sciences
Association for Laboratory Automation




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.